Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Intensity Therapeutics, Inc. (INTS)

NASDAQ

$3,96

$-0,01

(-0,35%)

Pre-Market

Intensity Therapeutics, Inc. (INTS) Live Price Chart

Last updated: ⁦2026-09-16 11:40:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Intensity Therapeutics, Inc. (INTS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3,96, with a market capitalisation of $12,99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,51 to $43,50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12,99M
Open	$3,97
Day's High	$286,00
Day's Low	$3,51
Previous Close	$3,81
Volume	277,00
Average Volume	40,87K
P/E Ratio	--
52-Week High	$43,50
52-Week Low	$3,51
Dividend Yield	--
Earnings Date	--

Intensity Therapeutics, Inc. (INTS) Pre-Market Stock Price

Intensity Therapeutics, Inc. (INTS) is trading at $3,96 in pre-market trading as of 2026-09-16 11:26:00, up 3,81% ($0,15) from the previous close of $3,81

Pre-market trading shows how investors are pricing INTS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Intensity Therapeutics, Inc. (INTS) 7-Day Stock Price Change

Over the past seven days, Intensity Therapeutics, Inc. (INTS) moved from $4,10 to $3,96, representing a decline of 3,54% ($0,14).

The stock traded between $3,81 and $4,13 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 10,86 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

INTS 52-Week Price Position

Position in Range: 1,1%

52W Low$3,51

52W High$43,50

INTS is currently trading at $3,96, placing it 1,1% of the way from its 52-week low of $3,51 to its 52-week high of $43,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Intensity Therapeutics, Inc. (INTS)?

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Intensity Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	7
Exchange	NASDAQ
Company Website	https://www.intensitytherapeutics.com

How to Buy Intensity Therapeutics, Inc. (INTS) Stock on MEXC

Eligible investors can buy real shares of Intensity Therapeutics, Inc. (INTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INTS and Place Your Order

Open the RealStocks trading page and search for INTS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Intensity Therapeutics, Inc. (INTS) stock price today?

Intensity Therapeutics, Inc. (INTS) is currently trading at $ 3,96, up 3,81% ($0,15) from the previous close of $ 3,81. Intraday prices update in real time during regular trading hours.

2.Is INTS stock going up or down today?

As of 2026-09-16 11:26:00, INTS is trading at $ 3,96, up 3,81% ($0,15) from its previous close of $ 3,81. The stock has traded between $ 3,51 and $ 286,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is INTS pre-market price?

As of 2026-09-16 11:26:00, INTS is trading at $ 3,96 in pre-market trading, up 3,81% ($0,15) from the previous close of $ 3,81. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INTS after-hours price?

As of 2026-09-16 11:26:00, INTS is trading at $ 3,97 in after-hours trading, up 4,15% ($0,16) from the regular-session close of $ 3,81. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INTS stock trading now?

INTS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INTS sit relative to its 52-week high and low?

Over the past 52 weeks, INTS has traded between a low of $ 3,51 and a high of $ 43,50. At $ 3,96, the stock is positioned 1,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Intensity Therapeutics, Inc. in?

Intensity Therapeutics, Inc. (INTS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Intensity Therapeutics, Inc.'s market capitalisation and where is it listed?

Intensity Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 12,99M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INTS valued in terms of P/E ratio and EPS?

INTS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3,42. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Intensity Therapeutics, Inc. pay a dividend?

Intensity Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.